Thomson Medical's FY2024 Earnings Plunges 57.8% to $15.4m
Thomson Medical's FY2024 Earnings Plunges 57.8% to $15.4m
Revenue for the period slightly dropped 1.3% YoY to $351.2m.Earnings per share stood at $0.058.
每股收益为0.058美元。
Thomson Medical Group (TMG) reported a 57.8% year-on-year (YoY) decline in earnings for FY2024 to $15.4m from $36.5m a year ago.
汤姆森医疗集团（TMG）报告称，FY2024 的收益同比下降57.8％，从去年同期的3650万美元降至1,540万美元。
Net profit for the period also slumped 52.5% YoY to $19.5m from $41.1m in FY2023.
该期间的净利润也从 FY2023 的4,110万美元同比下降了52.5％，至1,950万美元。
Revenue for the period slightly dropped 1.3% YoY to $351.2m.
该期间的收入同比略有下降1.3％，至3.512亿美元。
The group's EBITDA also slipped 0.9% YoY to $102.4m from $103.3m a year ago, impacted by long-term operations investments, lower income from COVID-19-related projects, and costs and foreign exchange losses from the acquisition of FV Hospital (FEMVN).
该集团的息税折旧摊销前利润也从去年同期的1.033亿美元同比下降0.9％至1.024亿美元，这受到长期运营投资、COVID-19相关项目收入减少以及收购FV医院（FEMVN）的成本和外汇损失的影响。
Earnings per share stood at $0.058 from $0.138 in the previous period.
每股收益为0.058美元，高于上一时期的0.138美元。
